Combining multi-site magnetic resonance imaging with machine learning predicts survival in pediatric brain tumors.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
23 09 2021
Historique:
received: 04 01 2021
accepted: 27 07 2021
entrez: 24 9 2021
pubmed: 25 9 2021
medline: 28 12 2021
Statut: epublish

Résumé

Brain tumors represent the highest cause of mortality in the pediatric oncological population. Diagnosis is commonly performed with magnetic resonance imaging. Survival biomarkers are challenging to identify due to the relatively low numbers of individual tumor types. 69 children with biopsy-confirmed brain tumors were recruited into this study. All participants had perfusion and diffusion weighted imaging performed at diagnosis. Imaging data were processed using conventional methods, and a Bayesian survival analysis performed. Unsupervised and supervised machine learning were performed with the survival features, to determine novel sub-groups related to survival. Sub-group analysis was undertaken to understand differences in imaging features. Survival analysis showed that a combination of diffusion and perfusion imaging were able to determine two novel sub-groups of brain tumors with different survival characteristics (p < 0.01), which were subsequently classified with high accuracy (98%) by a neural network. Analysis of high-grade tumors showed a marked difference in survival (p = 0.029) between the two clusters with high risk and low risk imaging features. This study has developed a novel model of survival for pediatric brain tumors. Tumor perfusion plays a key role in determining survival and should be considered as a high priority for future imaging protocols.

Identifiants

pubmed: 34556677
doi: 10.1038/s41598-021-96189-8
pii: 10.1038/s41598-021-96189-8
pmc: PMC8460620
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

18897

Subventions

Organisme : Cancer Research UK
ID : 10342
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 13457
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0601327
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom

Informations de copyright

© 2021. The Author(s).

Références

Childs Nerv Syst. 2021 Aug;37(8):2497-2508
pubmed: 33973057
Cancer Epidemiol Biomarkers Prev. 2014 Dec;23(12):2716-36
pubmed: 25192704
Korean J Radiol. 2019 Jan;20(1):134-147
pubmed: 30627029
Cancer. 2009 Dec 15;115(24):5761-70
pubmed: 19813274
Int J Surg Oncol. 2012;2012:245385
pubmed: 22312539
Neuroimage Clin. 2020;25:102172
pubmed: 32032817
Sci Rep. 2021 Feb 4;11(1):2987
pubmed: 33542327
Acta Neuropathol. 2013 Mar;125(3):359-71
pubmed: 23291781
Neuro Oncol. 2013 Apr;15(4):462-8
pubmed: 23502427
J Magn Reson Imaging. 2015 Feb;41(2):296-313
pubmed: 24817252
BMC Bioinformatics. 2009 Feb 26;10:72
pubmed: 19245714
JMIR Med Inform. 2018 May 02;6(2):e30
pubmed: 29720361
J Magn Reson Imaging. 2012 Apr;35(4):745-63
pubmed: 22434697
Sci Rep. 2017 Oct 18;7(1):13421
pubmed: 29044166
Radiology. 2015 Jun;275(3):783-91
pubmed: 25848905
Lancet Oncol. 2017 Jul;18(7):958-971
pubmed: 28545823
J Magn Reson Imaging. 2013 Aug;38(2):388-400
pubmed: 23281184
Cancer Res. 2014 Sep 1;74(17):4638-52
pubmed: 25183788
Eur J Cancer. 2013 Feb;49(3):658-67
pubmed: 23036849
Phys Med Biol. 2010 Oct 21;55(20):6157-74
pubmed: 20876970
Neurosurgery. 1998 Mar;42(3):470-5
pubmed: 9526979
J Cereb Blood Flow Metab. 2018 Sep;38(9):1461-1480
pubmed: 28598243
Br J Radiol. 2019 Feb;92(1094):20170872
pubmed: 30358415
Eur Radiol. 2012 Feb;22(2):447-57
pubmed: 21918916
Korean J Radiol. 2017 Jan-Feb;18(1):194-207
pubmed: 28096729
Neuroimage Clin. 2019;22:101696
pubmed: 30735859
Neuro Oncol. 2016 May;18(5):725-34
pubmed: 26487690

Auteurs

James T Grist (JT)

Institute of Cancer and Genomic Sciences, School of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.

Stephanie Withey (S)

Institute of Cancer and Genomic Sciences, School of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Oncology, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.
RRPPS, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

Christopher Bennett (C)

Institute of Cancer and Genomic Sciences, School of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.

Heather E L Rose (HEL)

Institute of Cancer and Genomic Sciences, School of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Oncology, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.

Lesley MacPherson (L)

Radiology, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.

Adam Oates (A)

Radiology, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.

Stephen Powell (S)

Institute of Cancer and Genomic Sciences, School of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.

Jan Novak (J)

Oncology, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.
Psychology, College of Health and Life Sciences Aston University, Birmingham, UK.
Aston Neuroscience Institute, Aston University, Birmingham, UK.

Laurence Abernethy (L)

Radiology, Alder Hey Children's NHS Foundation Trust, Liverpool, UK.

Barry Pizer (B)

Oncology, Alder Hey Children's NHS Foundation Trust, Liverpool, UK.

Simon Bailey (S)

Sir James Spence Institute of Child Health, Royal Victoria Infirmary, Newcastle upon Tyne, UK.

Steven C Clifford (SC)

Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, University of Newcastle, Newcastle upon Tyne, UK.

Dipayan Mitra (D)

Neuroradiology, Royal Victoria Infirmary, Newcastle Upon Tyne, UK.

Theodoros N Arvanitis (TN)

Institute of Cancer and Genomic Sciences, School of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Oncology, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.
Institute of Digital Healthcare, WMG, University of Warwick, Coventry, UK.

Dorothee P Auer (DP)

Sir Peter Mansfield Imaging Centre, University of Nottingham Biomedical Research Centre, Nottingham, UK.
NIHR Nottingham Biomedical Research Centre, Nottingham, UK.

Shivaram Avula (S)

Radiology, Alder Hey Children's NHS Foundation Trust, Liverpool, UK.

Richard Grundy (R)

The Children's Brain Tumor Research Centre, University of Nottingham, Nottingham, UK.

Andrew C Peet (AC)

Institute of Cancer and Genomic Sciences, School of Medical and Dental Sciences, University of Birmingham, Birmingham, UK. a.peet@bham.ac.uk.
Oncology, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK. a.peet@bham.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH